mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000

View company profile
Current Jobs

Regional Account Manager
Location: South East (including London)

Healthcare Policy Manager
Location: London North

Clinical Development Advisor
Location: Surrey

Novartis announces aid for Haiti earthquake victims

Posted on 18/01/2010 in Pharmaceutical Company Product News

Novartis has announced that it will provide $2.5 million (1.53 million pounds) for aid operations currently taking place in Haiti following the earthquake that hit the country last week.

The company will distribute the money through its local organisations, ensuring that the funds reach nationally recognised relief bodies.

Employees of the firm are also being encouraged to make donations to the aid efforts and Novartis has pledged to match these.

Additionally, essential medicines, such as pain-relieving drugs and antibiotics, will also be offered by the company to those in Haiti.

Dr Daniel Vasella, chairman and chief executive officer of Novartis, commented: "Our experience of providing support in the wake of natural disasters has proven successful, ensuring that we can get aid to the people in need fast and efficiently."

Last week, Novartis announced the availability of its latest product, Fanapt (iloperidone) tablets, which are indicated for use in adult patients suffering from schizophrenia.

Other news stories from 18/01/2010

Read more in the Zenopa News Archive

How this news is generated

James
Account Manager
for this opportunity

01494 818 002
(Mon to Fri 0830 to 1800 hours)
jamesh@zenopa.com

Latest News

Novartis to get priority review for multiple sclerosis drug

Novartis receives FDA approval for meningococcal disease vaccine

Novartis leukaemia drug to get priority FDA review

Novartis acquires exclusive rights to Debio 025

Novartis announces financial results for 2009

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use